Michelle Moorhouse

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

François Venter, Michelle Moorhouse, Simiso Sokhela et al. · New England Journal of Medicine · 2019 · 684 citations · Full text

Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial

François Venter, Simiso Sokhela, Bryony Simmons et al. · The Lancet HIV · 2020 · 249 citations

Week 96, Treatment And Prevention, Antiviral Drug Development +9

Adult antiretroviral therapy guidelines 2017

Graeme Meintjes, Michelle Moorhouse, Sergio Carmona et al. · Southern African Journal of HIV Medicine · 2017 · 190 citations · Full text

Southern African Journal, Antiretroviral Therapy, Preventive Medicine +13

Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study

Lucas E. Hermans, Michelle Moorhouse, Sergio Carmona et al. · The Lancet Infectious Diseases · 2017 · 163 citations

Antiretroviral Therapy, Treatment And Prevention, Human Retrovirus +7

HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project

Robyn Eakle, Gabriela B. Gomez, Niven Naicker et al. · PLoS Medicine · 2017 · 159 citations · Full text